{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:24:23Z","timestamp":1649093063160},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[1985,9]]},"abstract":"<jats:p>In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st., 7th. and 21st. days of oral administration (50mg\/kg\/day during 21 days). Samples of CSF and blood were collected three hours after the last administration of the daily total dosage, on the 1st. and 21st days; and from 2 to 6 hours after drug administration on the 7th. day. The total daily dosage was distributed into three equal parts of 1\/3 each, with a 4 hours' interval between intakes, except in the last 5 cases, who on the 21st. day only were given the total daily dosage on a single administration. Results have shown dispersion in serum concentrations, which are similar to those seen in normal subjects as recorded in literature. There is a correlation between PZQ levels in the CSF and in the serum, the latter being very close to those found in protein-free serum fraction. The statistical treatment of results allowed the following considerations: PZQ concentrations in the CSF and in the protein free serum are in balance from the pharmacodynamic standpoint on the first day; this balance is maintained up to the 21st. day although at different levels from those seen on the 7th. day; on the 21st. day PZQ contents in CSF goes back to its similar values as recorded on the 1st. day, and this suggests that the participation of drug interaction factors has been reduced to non-significant levels. However, several factors can influence PZQ concentration in CSF, as absorption rate, liver first-pass effect and blood-brain barrier changes, and individual dose should be established for each patient based on drug concentration monitoring in the serum and\/or in the CSF.<\/jats:p>","DOI":"10.1590\/s0004-282x1985000300003","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T06:11:18Z","timestamp":1345011078000},"page":"243-259","source":"Crossref","is-referenced-by-count":10,"title":["Praziquantel in the cerebrospinal fluid in neurocysticercosis"],"prefix":"10.1590","volume":"43","author":[{"given":"A.","family":"Spina-Fran\u00e7a","sequence":"first","affiliation":[{"name":"S\u00e3o Paulo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. R.","family":"Machado","sequence":"additional","affiliation":[{"name":"S\u00e3o Paulo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P. S.","family":"Nobrega","sequence":"additional","affiliation":[{"name":"S\u00e3o Paulo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Livramento","sequence":"additional","affiliation":[{"name":"S\u00e3o Paulo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. W.","family":"Diekmann","sequence":"additional","affiliation":[{"name":"Institute for Experimental Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Groll","sequence":"additional","affiliation":[{"name":"Medical Research Division"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L. de","family":"Rezende","sequence":"additional","affiliation":[{"name":"Research & Development Latin American Office"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/med.2610030204","article-title":"Praziquantel","volume":"3","author":"ANDREWS P.","year":"1983","journal-title":"Med. Res. Rev."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4269\/ajtmh.1982.31.811","article-title":"Treatment of cysticercosis with praziquantel in Colombia","volume":"31","author":"BOTERO D.","year":"1982","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref3","series-title":"The Concept of a Blood Brain Barrier","author":"BRADBURY M.","year":"1979"},{"key":"ref4","first-page":"66","article-title":"Neurocisticercosis: Tratamiento con praziquantel. Estudio preliminar","volume":"35","author":"BRINK G.","year":"1980","journal-title":"Bol. chil. Parasit."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03189504","article-title":"Metabolism of praziquantel in man","volume":"3","author":"B\u00dcHRING K.U.","year":"1978","journal-title":"Eur. J. Drug. Metabol. Pharmacok."},{"key":"ref6","first-page":"159","article-title":"Droncit en el tratamiento de la cisticercosis porcina","volume":"1","author":"CHAVARRIA; M.","year":"1978","journal-title":"Esp. Vet."},{"key":"ref7","first-page":"79","article-title":"Praziquantel no tratamento ambulatorial da neurocisticercose","volume":"45","author":"CRUZ M.","year":"1983","journal-title":"J. bras. Med."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03189416","article-title":"Quantitative determination of praziquantel in body fluids by gas liquid chromatography","volume":"3","author":"DIEKMANN H.W.","year":"1979","journal-title":"Eur. J. Drug. Metab. Pharmacok."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03189264","article-title":"The fate of praziquantel in the organism: III. Metabolism in rat, beagle dog and rhesus monkey","volume":"2","author":"DIEKMANN H.W.","year":"1976","journal-title":"Eur. J. Drug. Metabol. Pharmacok."},{"key":"ref10","first-page":"665","article-title":"Neurocqsticercosis treated with praziquantel","volume":"3","author":"GOMEZ J.G.","year":"1981","journal-title":"Neurol. col."},{"key":"ref11","first-page":"1983","article-title":"Cisticercosis, tratamiento con praziquantel: Abstracts, Symposium Internacional: Cisticid en Cisticercosis Cerebral","volume":"21","author":"GUARDERAS E.G.","journal-title":"Guayaquil, Oct."},{"key":"ref12","first-page":"102","article-title":"Medical management of neurocysticercosis with praziquantel","volume":"48","author":"LAWNER P.M.","year":"1983","journal-title":"Bull. clin. Neurose."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00560463","article-title":"Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes","volume":"14","author":"LEOPOLD G.","year":"1978","journal-title":"Eur. J. clin. Pharmacol."},{"key":"ref14","first-page":"17","article-title":"Tratamiento de la cisticercosis con praziquantel: Informe preliminar de diez casos","volume":"119","author":"LOMBARDO L.","year":"1983","journal-title":"Gac. m\u00e9d. M\u00e9x."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1590\/S0004-282X1981000400003","article-title":"Eosinofilorraquia em processos inflamat\u00f3rios do sistema nervoso central e seus envolt\u00f3rios","volume":"39","author":"MACHADO L.R.","year":"1981","journal-title":"Arq. Neuro-Psiquiat."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1984.33.273","article-title":"Cerebral cysticercosis: treatment with praziquantel","volume":"33","author":"MARKWALDER K.","year":"1984","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref17","first-page":"544","article-title":"In vivo and in vitro experiments on the effects of praziquantel on S: mansoni: a light and electron microscopy study","volume":"31","author":"MEHLHORN H.","year":"1981","journal-title":"Drug. Res."},{"key":"ref18","author":"MONTENEGRO R.L.","year":"1983"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJM198412063112307","article-title":"Recent advances in the diagnosis and treatment of cerebral cysticercosis","volume":"311","author":"NASH T.E.","year":"1984","journal-title":"N. Engl. J. Med.","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref20","first-page":"1","article-title":"Cisticercosis del sistema nervioso: Una evaluaci\u00f3n a corto plazo del tratamiento con praziquantel","volume":"47","author":"ORTIZ P.C.","year":"1984","journal-title":"Rev. Neuro-Psiquiat."},{"key":"ref21","author":"OVERBOSH D.","year":"1984"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF03189418","article-title":"Serum concentrations and renal excretion in human after oral administration of praziquantel","volume":"3","author":"PATZSCHEKE K.","year":"1979","journal-title":"Eur. J. Drug. Metab. Pharmacok."},{"issue":"17","key":"ref23","first-page":"459","article-title":"Studies on the human cysticercosis and its therapeutic trial with praziquantel","volume":"J","author":"RIM H.J.","year":"1980","journal-title":"Korea Univ. med."},{"key":"ref24","first-page":"443","article-title":"Tratamiento m\u00e9dico de la cisticercosis cerebral","volume":"23","author":"ROBLES C.C.","year":"1981","journal-title":"Sal. p\u00fabl. M\u00e9x."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM198404193101601","article-title":"Therapy of parenchymal brain cysticercosis with praziquantel","volume":"310","author":"SOTELO J.","year":"1984","journal-title":"New Engl. J. Med.","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref26","first-page":"385","article-title":"Cerebrospinal fluid immunobiology in neurocysticercosis","volume":"4","author":"SPINA-FRAN\u00c7A A.","year":"1962","journal-title":"Eur. Rev. med. pharmac. Sci."},{"key":"ref27","first-page":"34","article-title":"Neurocisticercose e praziquantel","volume":"95","author":"SPINA-FRAN\u00c7A A.","year":"1980","journal-title":"Rev. paul. Med.","ISSN":"http:\/\/id.crossref.org\/issn\/0035-0362","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0004-282X1981000300002","article-title":"Neurocisticercose e praziquantel: II. Avalia\u00e7\u00e3o dos resultados em 20 pacientes","volume":"39","author":"SPINA-FRAN\u00c7A A.","year":"1981","journal-title":"Arq. Neuro-Psiquiat."},{"key":"ref29","first-page":"1","article-title":"Administration of praziquantel in neurocysticercosis","volume":"33","author":"SPINA-FRAN\u00c7A A.","year":"1982","journal-title":"Tropenmed. Parasit."},{"key":"ref30","first-page":"85","article-title":"Neurocisticercose e praziquantel: avalia\u00e7\u00e3o dos resultados em 60 pacientes","volume":"45","author":"SPINA-FRAN\u00c7A A.","year":"1983","journal-title":"J. bras. Med."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03189263","article-title":"The fate of praziquantel in the organism: II. Distribution in rats","volume":"2","author":"STEINER K.","year":"1976","journal-title":"Eur. J. Drug. Metab. Pharmacok."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03189262","article-title":"The fate of praziquantel in the organism I: Pharmacokinetics in animals","volume":"2","author":"STEINER K.","year":"1976","journal-title":"Europ. J. Drug. Metabol. Pharmacok."},{"key":"ref33","author":"THOMAS H.","year":"1984"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4269\/ajtmh.1982.31.803","article-title":"New results on the effect of praziquantel in experimental cysticercosis","volume":"31","author":"THOMAS H.","year":"1982","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00389898","article-title":"The efficacy of praziquantel against cestodes in animals","volume":"52","author":"THOMAS H.","year":"1977","journal-title":"Z. Parasitenkd."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00384831","article-title":"Zur Wirksamkeit von Praziquantel bei der experimentellen Cysticercose und Hydatidose","volume":"55","author":"THOMAS H.","year":"1978","journal-title":"Z. Parasitenkd."}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v43n3\/03.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T04:36:59Z","timestamp":1495859819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X1985000300003&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["S0004-282X1985000300003"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x1985000300003","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}